Admera Health

Admera Health For every healthcare dollar spent on medications, an additional 50% is spent on addressing ADRs.

Admera Health is a leading precision medicine company providing a suite of high-integrity pharmacogenomics (PGx) solutions, diagnostic testing, and biopharmaceutical research services. PGx, the study of how genes affect a person’s response to drugs, combines the fields of pharmacology and genomics to develop effective, safe medications and dosing recommendations tailored to a person’s genetic makeup. PGx testing may help reduce adverse drug reactions (ADRs), which some estimates place as the fourth leading cause of death – resulting in more deaths than lung disease, diabetes, AIDS, pneumonia, and accidents. Admera Health’s flagship product, PGxOne™ Plus, is a comprehensive test built on the foundation of enabling smarter and safer medication management. The test incorporates next-generation gene sequencing design applications and expert data curation to deliver biological systems based medically actionable results. In addition to PGx services, Admera Health leverages existing knowledge and infrastructure to offer related clinical services and robust biopharmaceutical genomics solutions to researchers worldwide.

Wishing you a joyous holiday season with peace & cheer in the New Year!
12/24/2021

Wishing you a joyous holiday season with peace & cheer in the New Year!

Wishing you a joyful and memorable   to kick off a happy holiday season and a prosperous new year!
11/25/2021

Wishing you a joyful and memorable to kick off a happy holiday season and a prosperous new year!

March 24th is National Adverse Drug Event Awareness Day- DYK: Adverse drug reactions are among the leading causes of hos...
03/24/2021

March 24th is National Adverse Drug Event Awareness Day- DYK: Adverse drug reactions are among the leading causes of hospital visits, readmissions, and prolonged hospital stays, which places a significant burden on the healthcare system? Learn about how the PGxOne™ Plus test can help reduce adverse drug events: https://bit.ly/31fkN8T ,

This is a 403 error, and it's not as ominous as it sounds. Bitly can only show this page to people who have permission to see it. Maybe what you are looking for can be found at Bitly.com.

Goodbye  #2020! From all of us at Admera Health, Happy New Year! Wishing you and yours a year full of happiness and pros...
01/04/2021

Goodbye #2020! From all of us at Admera Health, Happy New Year! Wishing you and yours a year full of happiness and prosperity.

Congratulations to     Guanghui Hu, PhD, for being awarded EY US Entrepreneur Of The Year®!
10/08/2020

Congratulations to Guanghui Hu, PhD, for being awarded EY US Entrepreneur Of The Year®!

Admera Health CEO, Guanghui Hu, PhD, Awarded EY Entrepreneur Of The Year®EY Announces Winners for the Entrepreneur Of The Year® 2020 New Jersey AwardEY builds on three decades of honoring unstoppable entrepreneurs in New JerseyErnst & Young LLP (EY US) is pleased to announce the winners of the Ent...

Hygea Precision Medicine, Inc. and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnershi...
05/26/2020

Hygea Precision Medicine, Inc. and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership | Learn more:

Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership  May 26, 2020 SAN FRANCISCO, California and SOUTH PLAINFIELD, New Jersey, May 26, 2020 – Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for heal...

On Tuesday, February 25th, Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, CGMBS, presented at...
03/03/2020

On Tuesday, February 25th, Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, CGMBS, presented at Boston Children's Hospital, a Harvard Medical School Teaching Hospital, as part of its Metabolism Conference Series. His talk, entitled, "The Laboratory Approach to the Diagnosis of Porphyrias and their Impact in Precision Medicine," shed light into the relationship between diagnostic genes and pharmacogenomics. Learn more about PGx here: http://bit.ly/39fXM89

We're here! American Academy of Pain Medicine Annual Meeting - Stop by Booth  #231 to learn how Admera Health's PGxOne™ ...
02/28/2020

We're here! American Academy of Pain Medicine Annual Meeting - Stop by Booth #231 to learn how Admera Health's PGxOne™ Plus Test can provide relief to your patients' pain management regimen. http://bit.ly/3cimrL5

Address

126 Corporate Boulevard
South Plainfield, NJ
07080

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+19082220533

Alerts

Be the first to know and let us send you an email when Admera Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Admera Health:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Advancing Precision Medicine Beyond Diagnostics

Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health. Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. It is our mission to deliver transformative, valuable solutions for patients, physicians, and clinical researchers. We are committed to improving the health and well-being of our global community through the direct delivery of personalized, medically actionable results.